The effect of manipulation of basal pulsatile insulin on insulin action in Type 2 diabetes

Diabetic Medicine

Volumn 22, Issue 8, 2005, Pages 1064-1071

  Au, S ^a   Courtney, C H ^a   Ennis, C N ^a   Sheridan, B ^a   Atkinson, A B ^a   Bell, Patrick M ^a  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

Hyperinsulinaemic glucose clamps; Insulin action; Pulsatile insulin secretion; Type 2 diabetes

Indexed keywords

C PEPTIDE; GLUCAGON; GLUCOSE; INSULIN; NEUTRAL INSULIN; OCTREOTIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMAN; HYPERINSULINEMIA; INSULIN PUMP; INSULIN RELEASE; INSULIN SENSITIVITY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPERINSULINISM; INSULIN; MALE; MIDDLE AGED;

EID: 22644441822     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2005.01607.x     Document Type: Article

References (25)

1. Lang DA, Matthews DR, Peto J, Turner RC. Cyclic oscillations of basal plasma glucose and insulin concentrations in human beings. N Engl J Med 1979; 301: 1023-27.
2. Goodner CJ, Walike BC, Koerker DJ, Ensinck JW, Chideckel EW, Palmer J et al. Insulin, glucagon and glucose exhibit synchronous, sustained oscillations in fasting monkeys. Science 1977; 195: 177-179.
3. Song SH, McIntyre S, Shah H, Veldhuis JD, Hayes PC, Butler PC. Direct measurement of pulsatile insulin secretion from the portal vein in human subjects. J Clin Endocrinol Metab 2000; 85: 4491-4499.
4. Polonsky KS, Given BD, Van Cauter E. Twenty-four hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects. J Clin Invest 1988; 81: 442-448.
5. Sturis J, Van Cauter E, Blackman JD, Polonsky KS. Entrainmant of pulsatile insulin secretion by oscillatory glucose infusion. J Clin Invest 1991; 87: 439-445.
6. Wiggam I, Hunter SJ, Armstrong LV, Ennis C, Sheridan B, Atkinson AB et al. Insulin resistance and insulin pulsatility in essential hypertension. J Hyper 2000; 18: 743-748.
7. Dunaif A, Segal KR, Futterweit W, Dobransky A. Profound peripheral insulin resistance independent of obesity in polycystic ovary syndrome. Diabetes 1989; 38: 1165-1174.
8. Hunter SJ, Atkinson AB, Ennis CN, Sheridan B, Bell PM. Association between insulin secretory pulse frequency and peripheral insulin action in NIDDM and normal subjects. Diabetes 1996; 45: 683-686.
9. O'Rahilly S, Turner RC, Matthews D. Impaired pulsatile secretion of insulin in relatives of patients with non-insulin dependent diabetes. N Engl J Med 1988; 318: 1225-1230.
10. Schmitz O, Porksen N, Nyholm B, Skjaerbaek C, Butler PC, Veldhuis JD et al. Disorderly and non-stationary insulin secretion in relatives of patients with NIDDM. Am J Physiol 1997; 272: E218-E226.
11. Porksen N, Munn S, Steers J, Veldhuis JD, Butler PC. Impact of sampling technique on appraisal of pulsatile insulin secretion by deconvolution and cluster analysis. Am J Physiol 1995; 269: E 1106-1114.
12. Courtney CH, Atkinson AB, Ennis C, Sheridan B, Bell PM. Comparison of the priming effect of pulsatile with continuous insulin delivery on insulin action in man. Metabolism 2003; 52: 1050-1055.
13. Harper R, Ennis CN, Heaney AP, Sheridan B, Gormley M, Atkinson AB et al. A comparison of the effects of low and conventional dose thiazide diuretic on insulin action in hypertensive patients with non-insulin dependent diabetes mellitus. Diabetologia 1995; 38: 853-859.
14. Neely RDG, Rooney DP, Bell PM, Bell NP, Sheridan B, Atkinson AB. Influence of growth hormone on glucose-glucose 6 phosphate cycle and insulin action in normal humans. Am J Physiol 1992; 263: E980-E987.
15. Steele R, Wall JS, De Bodo RC, Altszuler N. Measurement of size and turnover rate of body glucose pool by the isotope dilution method. Am J Physiol 1956; 187: 15-25.
16. 14 glucose. Recent Prog Horm Res 1963; 19: 445-488.
17. Chou HF, Ipp E, Bowsher RR, Berman N, Ezrin C, Griffiths S. Sustained pulsatile insulin secretion from adenomatous human β cells. Diabetes 1991; 40: 1453-1458.
18. Sha L, Westerlund J, Szurszewski JH, Bergsten P. Amplitude modulation of pulsatile insulin secretion by intrapancreatic ganglion neurons. Diabetes 2001; 50: 51-55.
19. Paolisso G, Scheen AJ, Giugliano D, Sgambato S, Albert A, Varricchio M et al. Pulsatile insulin delivery has greater metabolic effects than continuous hormone administration in man: importance of pulse frequency. J Clin Endocrinol Metab 1991; 72: 607-615.
20. Paolisso G, Sgambato S, Gentile S, Memoli P, Giugliano D, Varricchio M et al. Advantageous metabolic effects of pulsatile insulin delivery in non-insulin dependent diabetic patients. J Clin Endocrinol Metab 1988; 67: 1005-1010.
21. Matthews DR, Frank M, Jackson R, Tosecu V, Alam S. Normal regular insulin oscillations are absent in gross obesity, old age and mild and severe type 2 diabetes. Diabetologia 1988; 31: 519A.
22. Zarkovic M, Ciric J, Stojanovic M, Penezic Z, Trbojevic B, Drezgic M et al. Effect of insulin sensitivity on pulsatile insulin secretion. Euro J Endocrinol 1999; 141: 494-501.
23. Zarkovic M, Ciric J, Penezic Z, Trbojevic B, Drezgic M. Effect of weight loss on the pulsatile insulin secretion. J Clin Endocrinol Metab 2000; 85: 3673-3677.
24. Baron AD, Zhu JS, Zhu JH, Weldon H, Maianu L, Garvey WT. Glucosamine induces insulin resistance in vivo by affecting GLUT 4 translocation in skeletal muscle. Implications for glucose toxicity. J Clin Invest 1995; 96: 2792-2801.
25. Matthews DR, Naylor BA, Jones RG, Ward GM, Turner RC. Pulsatile insulin has greater hypoglycaemic effect that continuous delivery. Diabetes 1983; 32: 617-621.